At a glance
- Originator GlaxoSmithKline
- Class Antifungals; Antineoplastics; Antiprotozoals
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Candidiasis; Pneumocystis pneumonia
Most Recent Events
- 25 Jan 2001 No-Development-Reported for Cancer in United Kingdom (Unknown route)
- 25 Jan 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 25 Jan 2001 No-Development-Reported for Candidiasis in United Kingdom (Unknown route)